Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Hormone-Releasing Hormone | 17 | 2024 | 128 | 5.080 |
Why?
|
Human Growth Hormone | 14 | 2020 | 638 | 2.140 |
Why?
|
Intra-Abdominal Fat | 11 | 2023 | 612 | 1.930 |
Why?
|
Williams Syndrome | 4 | 2021 | 193 | 1.720 |
Why?
|
Fatty Liver | 6 | 2020 | 789 | 1.710 |
Why?
|
HIV Infections | 46 | 2024 | 17347 | 1.520 |
Why?
|
Insulin-Like Growth Factor I | 14 | 2021 | 1931 | 1.500 |
Why?
|
Body Composition | 18 | 2021 | 2422 | 1.440 |
Why?
|
Dwarfism, Pituitary | 2 | 2020 | 39 | 1.100 |
Why?
|
Adiposity | 12 | 2024 | 1877 | 1.050 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 3 | 2017 | 138 | 0.790 |
Why?
|
Genitalia | 1 | 2022 | 113 | 0.790 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2021 | 116 | 0.720 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 208 | 0.680 |
Why?
|
Menstruation | 1 | 2021 | 307 | 0.670 |
Why?
|
Obesity | 23 | 2024 | 12938 | 0.660 |
Why?
|
Anti-Obesity Agents | 2 | 2020 | 227 | 0.650 |
Why?
|
Endocrinology | 2 | 2022 | 442 | 0.640 |
Why?
|
Blood Glucose | 13 | 2021 | 6391 | 0.630 |
Why?
|
Bone Density | 3 | 2021 | 3551 | 0.590 |
Why?
|
Growth Hormone | 4 | 2020 | 569 | 0.530 |
Why?
|
Insulin Resistance | 7 | 2018 | 3963 | 0.520 |
Why?
|
Subcutaneous Fat | 4 | 2021 | 393 | 0.490 |
Why?
|
Liver | 10 | 2023 | 7532 | 0.480 |
Why?
|
Carotid Arteries | 4 | 2013 | 941 | 0.470 |
Why?
|
Adrenal Insufficiency | 3 | 2023 | 194 | 0.470 |
Why?
|
Lipid Metabolism | 4 | 2018 | 1902 | 0.460 |
Why?
|
Anti-HIV Agents | 6 | 2020 | 4525 | 0.450 |
Why?
|
Abdominal Fat | 2 | 2014 | 221 | 0.430 |
Why?
|
Weight Loss | 5 | 2020 | 2683 | 0.430 |
Why?
|
Quinolines | 1 | 2018 | 764 | 0.430 |
Why?
|
Pituitary Gland | 2 | 2018 | 635 | 0.420 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 416 | 0.420 |
Why?
|
Double-Blind Method | 9 | 2024 | 12330 | 0.390 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 867 | 0.390 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2010 | 584 | 0.380 |
Why?
|
HIV | 6 | 2023 | 1582 | 0.350 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 277 | 0.350 |
Why?
|
Metabolic Diseases | 2 | 2014 | 681 | 0.350 |
Why?
|
HIV Protease Inhibitors | 4 | 2009 | 432 | 0.330 |
Why?
|
Adrenoleukodystrophy | 2 | 2023 | 143 | 0.330 |
Why?
|
HIV Wasting Syndrome | 8 | 2001 | 97 | 0.310 |
Why?
|
Adipokines | 1 | 2010 | 310 | 0.310 |
Why?
|
Tunica Media | 3 | 2013 | 112 | 0.290 |
Why?
|
Overweight | 1 | 2018 | 2413 | 0.290 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3244 | 0.280 |
Why?
|
Placebos | 6 | 2024 | 1667 | 0.280 |
Why?
|
Humans | 99 | 2024 | 761423 | 0.280 |
Why?
|
Glucose Clamp Technique | 3 | 2018 | 263 | 0.280 |
Why?
|
Adult | 57 | 2024 | 221148 | 0.280 |
Why?
|
Cardiovascular Diseases | 12 | 2023 | 15498 | 0.270 |
Why?
|
Insulin | 6 | 2018 | 6602 | 0.260 |
Why?
|
Parathyroid Hormone | 1 | 2012 | 1803 | 0.260 |
Why?
|
C-Reactive Protein | 3 | 2013 | 3823 | 0.260 |
Why?
|
Phosphocreatine | 3 | 2010 | 261 | 0.260 |
Why?
|
Adolescent | 27 | 2022 | 88313 | 0.260 |
Why?
|
Female | 63 | 2024 | 392581 | 0.260 |
Why?
|
Male | 68 | 2024 | 360736 | 0.250 |
Why?
|
Body Mass Index | 13 | 2023 | 12951 | 0.250 |
Why?
|
Blood Proteins | 2 | 2021 | 1180 | 0.250 |
Why?
|
Tunica Intima | 3 | 2013 | 458 | 0.250 |
Why?
|
Young Adult | 22 | 2022 | 59207 | 0.250 |
Why?
|
Middle Aged | 48 | 2024 | 220826 | 0.250 |
Why?
|
Inflammation | 6 | 2024 | 10762 | 0.250 |
Why?
|
Testosterone | 9 | 2019 | 2472 | 0.240 |
Why?
|
Body Height | 3 | 2010 | 1570 | 0.240 |
Why?
|
Minority Groups | 2 | 2021 | 1203 | 0.230 |
Why?
|
Monocytes | 4 | 2022 | 2572 | 0.230 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2008 | 376 | 0.220 |
Why?
|
Vitamin D | 2 | 2019 | 3301 | 0.220 |
Why?
|
Muscle, Skeletal | 7 | 2015 | 4946 | 0.220 |
Why?
|
Renin-Angiotensin System | 3 | 2018 | 737 | 0.210 |
Why?
|
Lipodystrophy | 3 | 2016 | 148 | 0.210 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4549 | 0.190 |
Why?
|
Alanine Transaminase | 3 | 2021 | 603 | 0.190 |
Why?
|
Case-Control Studies | 11 | 2020 | 22168 | 0.180 |
Why?
|
Absorptiometry, Photon | 5 | 2024 | 1737 | 0.180 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1179 | 0.170 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2018 | 282 | 0.170 |
Why?
|
Heart | 4 | 2022 | 4405 | 0.160 |
Why?
|
Body Weight | 6 | 2023 | 4618 | 0.160 |
Why?
|
Proteomics | 3 | 2023 | 3845 | 0.160 |
Why?
|
Growth Substances | 1 | 2021 | 768 | 0.160 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2020 | 1896 | 0.150 |
Why?
|
Aspartate Aminotransferases | 2 | 2017 | 416 | 0.150 |
Why?
|
Growth Disorders | 1 | 2022 | 653 | 0.150 |
Why?
|
Eating | 2 | 2023 | 1538 | 0.150 |
Why?
|
HIV-1 | 4 | 2019 | 6860 | 0.140 |
Why?
|
Glucose | 1 | 2009 | 4347 | 0.140 |
Why?
|
gamma-Glutamyltransferase | 1 | 2017 | 144 | 0.140 |
Why?
|
Myocardium | 2 | 2020 | 4725 | 0.140 |
Why?
|
Fibrosis | 2 | 2022 | 2048 | 0.140 |
Why?
|
Child | 11 | 2023 | 80162 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2019 | 3769 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1806 | 0.130 |
Why?
|
Cranial Irradiation | 1 | 2018 | 390 | 0.130 |
Why?
|
Hormones | 1 | 2019 | 869 | 0.130 |
Why?
|
Emergency Treatment | 1 | 2019 | 496 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2018 | 553 | 0.120 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1148 | 0.120 |
Why?
|
Treatment Outcome | 9 | 2024 | 64651 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2015 | 393 | 0.110 |
Why?
|
Triglycerides | 2 | 2019 | 2460 | 0.110 |
Why?
|
Adipose Tissue | 6 | 2024 | 3312 | 0.110 |
Why?
|
Hypothalamus | 1 | 2018 | 999 | 0.110 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2019 | 550 | 0.110 |
Why?
|
Ideal Body Weight | 1 | 2012 | 27 | 0.110 |
Why?
|
California | 1 | 2017 | 1427 | 0.100 |
Why?
|
Glucose Transporter Type 2 | 1 | 2012 | 61 | 0.100 |
Why?
|
Hypercalciuria | 1 | 2012 | 31 | 0.100 |
Why?
|
Hypophosphatemia, Familial | 1 | 2012 | 32 | 0.100 |
Why?
|
Aged | 14 | 2021 | 169235 | 0.100 |
Why?
|
Fanconi Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
Lipids | 6 | 2018 | 3340 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2152 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1708 | 0.100 |
Why?
|
Macrophages | 2 | 2024 | 5768 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Rickets | 1 | 2012 | 70 | 0.100 |
Why?
|
Fibronectins | 1 | 2015 | 723 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2119 | 0.100 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 2821 | 0.100 |
Why?
|
Hypogonadism | 5 | 2019 | 798 | 0.100 |
Why?
|
Age Determination by Skeleton | 1 | 2012 | 126 | 0.100 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.090 |
Why?
|
Societies | 2 | 2021 | 108 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1032 | 0.090 |
Why?
|
Heart Failure | 4 | 2022 | 11674 | 0.090 |
Why?
|
Plaque, Atherosclerotic | 1 | 2022 | 1530 | 0.090 |
Why?
|
Sodium | 1 | 2016 | 1588 | 0.090 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1964 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1189 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2023 | 3187 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20556 | 0.090 |
Why?
|
Sulfotransferases | 1 | 2011 | 150 | 0.090 |
Why?
|
Antigens, CD | 2 | 2018 | 4001 | 0.090 |
Why?
|
Longitudinal Studies | 6 | 2023 | 14599 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1862 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2023 | 26212 | 0.090 |
Why?
|
Gene Expression | 2 | 2020 | 7584 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1201 | 0.080 |
Why?
|
Anti-Retroviral Agents | 3 | 2020 | 1782 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2019 | 2161 | 0.080 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4354 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2569 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1386 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2012 | 642 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 3204 | 0.080 |
Why?
|
Adiponectin | 2 | 2011 | 1113 | 0.080 |
Why?
|
Exercise | 5 | 2010 | 5884 | 0.080 |
Why?
|
E-Selectin | 1 | 2010 | 576 | 0.080 |
Why?
|
Immunity | 2 | 2024 | 997 | 0.070 |
Why?
|
Ritonavir | 1 | 2009 | 329 | 0.070 |
Why?
|
Adrenal Glands | 2 | 2008 | 552 | 0.070 |
Why?
|
Body Fat Distribution | 1 | 2009 | 245 | 0.070 |
Why?
|
Lipoproteins, HDL | 1 | 2012 | 675 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8633 | 0.070 |
Why?
|
Liver Cirrhosis | 3 | 2023 | 1934 | 0.070 |
Why?
|
Neonatal Screening | 2 | 2023 | 597 | 0.070 |
Why?
|
Pyrimidinones | 1 | 2009 | 385 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3407 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3905 | 0.070 |
Why?
|
Puberty | 1 | 2009 | 501 | 0.070 |
Why?
|
Neck | 1 | 2011 | 734 | 0.070 |
Why?
|
Prevalence | 5 | 2020 | 15717 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2010 | 0.070 |
Why?
|
Obesity, Morbid | 2 | 2014 | 1277 | 0.070 |
Why?
|
Ovary | 2 | 2008 | 959 | 0.060 |
Why?
|
Luteinizing Hormone | 1 | 2008 | 820 | 0.060 |
Why?
|
Metabolome | 1 | 2012 | 987 | 0.060 |
Why?
|
Sex Characteristics | 3 | 2010 | 2637 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12143 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 818 | 0.060 |
Why?
|
Prediabetic State | 1 | 2010 | 549 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 877 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6231 | 0.060 |
Why?
|
Blood Pressure | 5 | 2020 | 8487 | 0.060 |
Why?
|
Oxidative Phosphorylation | 2 | 2020 | 496 | 0.060 |
Why?
|
Diet, Sodium-Restricted | 2 | 2016 | 292 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2014 | 992 | 0.060 |
Why?
|
Oligopeptides | 1 | 2009 | 1187 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7389 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15838 | 0.050 |
Why?
|
Steroids | 1 | 2008 | 929 | 0.050 |
Why?
|
Hydrocortisone | 3 | 2019 | 1815 | 0.050 |
Why?
|
Aging | 2 | 2020 | 8705 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29620 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3623 | 0.050 |
Why?
|
United States | 6 | 2021 | 72339 | 0.050 |
Why?
|
HIV Integrase Inhibitors | 1 | 2024 | 165 | 0.050 |
Why?
|
Aldosterone | 2 | 2018 | 870 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 18400 | 0.050 |
Why?
|
Risk Factors | 8 | 2023 | 74167 | 0.050 |
Why?
|
Viral Load | 3 | 2020 | 3330 | 0.050 |
Why?
|
Hawaii | 1 | 2021 | 102 | 0.050 |
Why?
|
Potassium Radioisotopes | 1 | 2000 | 12 | 0.050 |
Why?
|
Appetite | 1 | 2023 | 247 | 0.050 |
Why?
|
Weight Gain | 2 | 2023 | 2347 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1871 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 301 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 459 | 0.050 |
Why?
|
Child, Preschool | 3 | 2018 | 42254 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2273 | 0.040 |
Why?
|
Mitochondria, Muscle | 2 | 2010 | 172 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 652 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11902 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39117 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Arteries | 1 | 2024 | 1124 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6395 | 0.040 |
Why?
|
Cohort Studies | 4 | 2021 | 41446 | 0.040 |
Why?
|
Arginine | 3 | 2010 | 933 | 0.040 |
Why?
|
Genetic Testing | 1 | 2012 | 3538 | 0.040 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 43 | 0.040 |
Why?
|
Hepatitis | 1 | 2020 | 229 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2023 | 1186 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3879 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6485 | 0.040 |
Why?
|
Reference Values | 3 | 2018 | 4921 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 26112 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2875 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 629 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9031 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2000 | 400 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 618 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 2018 | 249 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2018 | 629 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29862 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2100 | 0.030 |
Why?
|
Waist Circumference | 1 | 2019 | 934 | 0.030 |
Why?
|
North America | 1 | 2018 | 1276 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 80582 | 0.030 |
Why?
|
Regression Analysis | 3 | 2012 | 6343 | 0.030 |
Why?
|
Androgens | 1 | 2001 | 1286 | 0.030 |
Why?
|
Muscles | 1 | 1999 | 1576 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 605 | 0.030 |
Why?
|
Up-Regulation | 1 | 2023 | 4124 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36423 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 5840 | 0.030 |
Why?
|
Hypopituitarism | 1 | 2015 | 250 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20093 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2017 | 857 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2000 | 928 | 0.030 |
Why?
|
Transaminases | 1 | 2014 | 198 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10498 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2012 | 14 | 0.030 |
Why?
|
Aorta | 1 | 2020 | 2041 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1638 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2014 | 523 | 0.030 |
Why?
|
Angiotensin II | 1 | 2015 | 848 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.020 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 374 | 0.020 |
Why?
|
Energy Metabolism | 2 | 2015 | 2881 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23441 | 0.020 |
Why?
|
Models, Biological | 1 | 2008 | 9469 | 0.020 |
Why?
|
Spleen | 1 | 2017 | 2295 | 0.020 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2012 | 113 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2000 | 2199 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13502 | 0.020 |
Why?
|
Prospective Studies | 4 | 2022 | 54415 | 0.020 |
Why?
|
Kidney Tubules, Proximal | 1 | 2012 | 383 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3490 | 0.020 |
Why?
|
Genes, Recessive | 1 | 2012 | 628 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5497 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 174 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2918 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2012 | 963 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2298 | 0.020 |
Why?
|
Particle Size | 1 | 2012 | 1646 | 0.020 |
Why?
|
Family Health | 1 | 2012 | 1257 | 0.020 |
Why?
|
Oocytes | 1 | 2012 | 1166 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2000 | 3728 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2019 | 3057 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2507 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2011 | 771 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10548 | 0.020 |
Why?
|
Thinness | 1 | 2008 | 490 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 1349 | 0.010 |
Why?
|
Pedigree | 1 | 2012 | 4589 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4320 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6178 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10203 | 0.010 |
Why?
|
Cholesterol, HDL | 2 | 2000 | 1814 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2382 | 0.010 |
Why?
|
Leptin | 1 | 2011 | 1597 | 0.010 |
Why?
|
Exercise Test | 1 | 2010 | 2129 | 0.010 |
Why?
|
Cosyntropin | 1 | 2001 | 34 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12058 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36205 | 0.010 |
Why?
|
Motor Activity | 1 | 2010 | 2711 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2001 | 241 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 2000 | 161 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13449 | 0.010 |
Why?
|
Scintillation Counting | 1 | 2000 | 36 | 0.010 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.010 |
Why?
|
Viscera | 1 | 2001 | 138 | 0.010 |
Why?
|
Wasting Syndrome | 1 | 2000 | 98 | 0.010 |
Why?
|
Weight Lifting | 1 | 2000 | 130 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2977 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9535 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17644 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 457 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 2000 | 554 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9612 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1998 | 321 | 0.010 |
Why?
|
Arm | 1 | 2000 | 590 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2000 | 621 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5970 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6581 | 0.010 |
Why?
|
Physical Fitness | 1 | 2001 | 739 | 0.010 |
Why?
|
Electric Impedance | 1 | 2000 | 756 | 0.010 |
Why?
|
Lipoproteins | 1 | 2001 | 881 | 0.010 |
Why?
|
Leg | 1 | 2000 | 1089 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1999 | 753 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58956 | 0.010 |
Why?
|
Abdomen | 1 | 2001 | 1128 | 0.010 |
Why?
|
Energy Intake | 1 | 2001 | 2134 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12688 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 1999 | 2076 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8542 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2691 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2000 | 6019 | 0.010 |
Why?
|
Massachusetts | 1 | 2000 | 8832 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4481 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81509 | 0.000 |
Why?
|
Phenotype | 1 | 2000 | 16606 | 0.000 |
Why?
|
Animals | 1 | 2012 | 168441 | 0.000 |
Why?
|
Quality of Life | 1 | 1999 | 13361 | 0.000 |
Why?
|
Time Factors | 1 | 1999 | 39975 | 0.000 |
Why?
|